Bought
Maintained
Sold
Other funds holding PFE
ADE LLC's PFE Position: Q3 2026 in Review
ADE LLC held its Pfizer (PFE) position steady in Q3 2026 at 10,708 shares worth $305K. The position accounts for 0.12% of the portfolio, ranked #77.
ADE LLC first reported a position in PFE in Q4 2020 and has held it in 24 quarters since. The position peaked at $790K in Q4 2021. 1,568 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- ADE LLC held 10,708 shares of Pfizer worth $305K as of Q3 2026.
- ADE LLC left its Pfizer share count unchanged in Q3 2026.
- Pfizer made up 0.12% of ADE LLC's portfolio in Q3 2026, its #77 holding.
- ADE LLC first reported a position in Pfizer in Q4 2020 and has held it in 24 quarters since.
- ADE LLC's Pfizer position peaked at $790K in Q4 2021.
- 1,568 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on ADE LLC's 13F filing for Q3 2026, filed 29 Oct 2026.